MedPage Today on MSN
The Chase Is Still On in Heart Pump Innovation
New concepts in device therapy for advanced heart failure presented in early reports ...
Decatur, Ga.-based Emory Heart and Vascular Center completed its 500th left ventricular assist device implantation. This year alone, Emory surgeons have implanted approximately 60 LVADs and expect to ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The HeartMate II Left Ventricular ...
'Destination therapy' is a term that refers to the implantation of a left ventricular assist device (LVAD) with the aim of providing permanent circulatory support to people with advanced heart failure ...
Every year, around 50,000 people in the United States experience cardiogenic shock - a life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood ...
Cardiac surgeons and heart failure specialists at Michigan Medicine are testing a new left ventricular assist device developed by BrioHealth Solutions called BrioVAD. The trial, known as the INNOVATE ...
Outcomes and expenses were similar with transplant and elective LVAD, but urgent LVAD after ECMO fared much worse.
Please provide your email address to receive an email when new articles are posted on . There is only one mechanical heart pump available in the U.S. for patients with heart failure requiring left ...
More than one-quarter of pediatric patients on ventricular assist devices were able to have their devices explanted due to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results